Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Title:
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Author:
Lampson, Benjamin L. Kasar, Siddha N. Matos, Tiago R. Morgan, Elizabeth A. Rassenti, Laura Davids, Matthew S. Fisher, David C. Freedman, Arnold S. Jacobson, Caron A. Armand, Philippe Abramson, Jeremy S. Arnason, Jon E. Kipps, Thomas J. Fein, Joshua Fernandes, Stacey Hanna, John Ritz, Jerome Kim, Haesook T. Brown, Jennifer R.